STOCK TITAN

[Form 4] NEOGEN CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Insider report: A director of Neogen Corporation (NEOG) had 2,071 restricted stock units vest and be settled for 2,071 shares of common stock on 10/07/2025. The transaction is recorded as a vesting/settlement (code M) with an indicated price of $5.63 per share. After the settlement the reporting person beneficially owned 92,545 shares. The Form 4 was signed on 10/09/2025.

Rapporto degli insider: Un direttore di Neogen Corporation (NEOG) ha maturato e liquidato 2.071 unità di azioni vincolate per 2.071 azioni ordinarie in data 10/07/2025. La transazione è registrata come vesting/settlement (codice M) con prezzo indicato di $5,63 per azione. Dopo la liquidazione, la persona che segnala possedeva beneficiariamente 92.545 azioni. Il Form 4 è stato firmato in data 10/09/2025.

Informe de insider: Un director de Neogen Corporation (NEOG) ha consolidado y liquidado 2.071 unidades de acciones restringidas por 2.071 acciones ordinarias en la fecha 10/07/2025. La transacción se registra como vesting/settlement (código M) con un precio indicado de $5,63 por acción. Después del acuerdo, la persona que reporta poseía beneficiosamente 92.545 acciones. El Formulario 4 fue firmado en la fecha 10/09/2025.

인사이더 보고서: 네오젠 코퍼레이션(NEOG)의 한 이사가 2,071개의 제한 주식 단위(RSU)가 귀속되어 2,071주의 보통주로 해결되었습니다. 날짜는 10/07/2025이며, 이 거래는 vesting/settlement(코드 M)로 기록되었고 주당 표시 가격은 $5.63입니다. 정산 후 보고자는 92,545주의 실질적 소유권을 가지게 되었습니다. Form 4는 10/09/2025에 서명되었습니다.

Rapport d’initié : Un administrateur de Neogen Corporation (NEOG) a vesté et réglé 2.071 unités d’actions restreintes pour 2.071 actions ordinaires à la date 10/07/2025. La transaction est enregistrée comme vesting/settlement (code M) avec un prix indiqué de $5,63 par action. Après le règlement, la personne déclarant détenait bénéficiaiement 92.545 actions. Le formulaire 4 a été signé le 10/09/2025.

Insider-Bericht: Ein Direktor von Neogen Corporation (NEOG) hat 2.071 Restricted-Stock-Units (RSUs) vesten und für 2.071 Stammaktien settled am 10/07/2025. Die Transaktion wird als Vesting/Settlement (Code M) mit einem angegebenen Preis von $5.63 pro Aktie registriert. Nach der Abwicklung besaß die meldende Person wohltuend 92.545 Aktien. Das Formular 4 wurde am 10/09/2025 unterschrieben.

تقرير الداخل: كان لدى مدير من Neogen Corporation (NEOG) 2,071 وحدة أسهم مقيدة vest وتم تسويتها مقابل 2,071 سهم من الأسهم العادية في تاريخ 10/07/2025. تم تسجيل الصفقة كـ vesting/settlement (الرمز M) بسعر مذكور قدره $5.63 للسهم الواحد. بعد التسوية، امتلك الشخص المبلغ تقنيًا 92,545 سهمًا. تم توقيع النموذج 4 في 10/09/2025.

内部人士报告: Neogen Corporation (NEOG) 的一名董事在 10/07/2025 的日期完成了 2,071 份受限股票单位(RSU)的归属并以 2,071 股普通股结清。该交易记为归属/结算(代码 M),标示价格为每股 $5.63。结清后,报告人实际持有 92,545 股。Form 4 于 10/09/2025 签署。

Positive
  • Routine compensation settlement: 2,071 RSUs vested and converted to shares, reflecting normal director pay
  • Transparency: Transaction reported on Form 4 and signed on 10/09/2025, providing timely disclosure
Negative
  • None.

Insights

Director RSUs vested and were settled into common shares.

The filing records the contractual vesting and settlement of 2,071 restricted stock units into the same number of common shares on 10/07/2025, recorded under transaction code M which denotes a settlement of a previously granted award.

This is a routine, non‑market transaction tied to compensation, not an open‑market trade; investors may note that the reporting person holds 92,545 shares after the settlement, which is the disclosed beneficial ownership level to monitor over time.

Rapporto degli insider: Un direttore di Neogen Corporation (NEOG) ha maturato e liquidato 2.071 unità di azioni vincolate per 2.071 azioni ordinarie in data 10/07/2025. La transazione è registrata come vesting/settlement (codice M) con prezzo indicato di $5,63 per azione. Dopo la liquidazione, la persona che segnala possedeva beneficiariamente 92.545 azioni. Il Form 4 è stato firmato in data 10/09/2025.

Informe de insider: Un director de Neogen Corporation (NEOG) ha consolidado y liquidado 2.071 unidades de acciones restringidas por 2.071 acciones ordinarias en la fecha 10/07/2025. La transacción se registra como vesting/settlement (código M) con un precio indicado de $5,63 por acción. Después del acuerdo, la persona que reporta poseía beneficiosamente 92.545 acciones. El Formulario 4 fue firmado en la fecha 10/09/2025.

인사이더 보고서: 네오젠 코퍼레이션(NEOG)의 한 이사가 2,071개의 제한 주식 단위(RSU)가 귀속되어 2,071주의 보통주로 해결되었습니다. 날짜는 10/07/2025이며, 이 거래는 vesting/settlement(코드 M)로 기록되었고 주당 표시 가격은 $5.63입니다. 정산 후 보고자는 92,545주의 실질적 소유권을 가지게 되었습니다. Form 4는 10/09/2025에 서명되었습니다.

Rapport d’initié : Un administrateur de Neogen Corporation (NEOG) a vesté et réglé 2.071 unités d’actions restreintes pour 2.071 actions ordinaires à la date 10/07/2025. La transaction est enregistrée comme vesting/settlement (code M) avec un prix indiqué de $5,63 par action. Après le règlement, la personne déclarant détenait bénéficiaiement 92.545 actions. Le formulaire 4 a été signé le 10/09/2025.

Insider-Bericht: Ein Direktor von Neogen Corporation (NEOG) hat 2.071 Restricted-Stock-Units (RSUs) vesten und für 2.071 Stammaktien settled am 10/07/2025. Die Transaktion wird als Vesting/Settlement (Code M) mit einem angegebenen Preis von $5.63 pro Aktie registriert. Nach der Abwicklung besaß die meldende Person wohltuend 92.545 Aktien. Das Formular 4 wurde am 10/09/2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BOREL JAMES C

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/07/2025 M 2,071 A $5.63 92,545 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $5.63 10/07/2025 M 2,071 10/07/2025 10/07/2025 Common Stock 2,071 $5.63 0 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On October 7, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What happened in the NEOG Form 4 filed on 10/09/2025?

A director had 2,071 restricted stock units vest and be settled for 2,071 common shares on 10/07/2025 at an indicated price of $5.63.

How many NEOG shares does the reporting person own after the transaction?

The reporting person beneficially owned 92,545 shares following the settlement.

What does transaction code M mean on the Form 4 for NEOG?

Code M indicates a transaction where securities were acquired by means of the settlement of a restricted stock unit or similar award; here RSUs vested and were settled into shares.

Was this an open-market purchase or sale for NEOG (NEOG)?

No; this was a compensation-related settlement of RSUs into shares, not an open-market trade.

What price is shown for the settled RSUs on the NEOG Form 4?

The Form shows an indicated price of $5.63 per share for the settled RSUs.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.47B
215.23M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING